Eveia’s Core Technology achieves extremely high sensitivity through optical system design that is carefully coordinated with fluorescent dye selection. A diode laser is used for excitation. By passing the laser through the electrophoresis capture layer the detection system can monitor the capture process and even monitor what is not captured, an important feature for competitive binding assays. The Technology is being developed in phases:

Eveia’s Core Technology is being designed as a modular system that can be integrated into existing platforms. Eveia is actively seeking commercialization partners with established customers and distribution channels in the global IVD market place. Co-development and licensing opportunities for use of Eveia Core Technology in existing clinical systems can be explored.